NFE2L2 and lung carcinoma: Among a total of 387 lung cancer patients, we found that SNP (c.–617C>A) in the NRF2 gene is a prognostic biomarker for assessing the gender (female)-related risk of lung adenocarcinomas in the Japanese non-smoking sub-population of lung cancer patients.